HUC-MSC for Treatment of High-risk HPV Infection

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

September 10, 2025

Study Completion Date

September 10, 2026

Conditions
Human Papillomavirus VirusesMesenchymal Stem Cells
Interventions
BIOLOGICAL

hUC-MSCs

1×10\^6/Kg hUC-MSCs (suspended in 100 mL normal saline containing 5% albumin) are infused intravenously to patients at a controlled rate of 60-80 drops/min.

BIOLOGICAL

Saline+albumin

Normal saline containing 5% albumin had a similar suspension and appearance package to hUC-MSCs, but no MSCs

Trial Locations (1)

200120

RECRUITING

Shanghai Shanghai East Hospital, Tongji University School of Medicine, Shanghai

All Listed Sponsors
lead

Shanghai East Hospital

OTHER